T2DM results from the progressive dysfunction of pancreatic β‐cells, alongside decreased sensitivity of peripheral tissues to insulin (Artasensi et al. 2020; Chatterjee et al. 2017; American Diabetes Association Professional Practice 2024). This evidence concerns the gene INS and type 2 diabetes mellitus.